Results of a subsequent study indicated that myostatin and its receptors expression rise significantly in deep infiltrating endometriosis and endometrial adenocarcinoma in comparison to control endometrium, which suggests a potential role of myostatin in the aforementioned disorders [185]. The gene discussed is MSTN; the disease is endometriosis.